Kesar Pharma Limited - Company Profile

It is a pharma public limited company based in Gandhinagar, Gujarat, India, established in 2011.
2011 Gandhinagar, Gujarat, India Active
Last Updated:
Access Report
About Kesar Pharma Limited

Kesar Pharma Limited, a active public limited company, was established on 18 October 2011 in Gandhinagar, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239GJ2011PLC067520. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.90 Cr and a paid-up capital of ₹4.32 Cr.

Formerly known as Kesar Swasthya Private Limited. It upholds a compliant status. Employing 47 professional, Its leadership includes Parth Hemant Parikh (Director), Kevin Atul Vasani (Director), Prakash Ambalal Patel (Director). Past directors included Dhruma Jigarbhai Shah, Hemant Amrish Parikh, Parth Hemant Parikh. It holds ₹10.58 Cr open charges and ₹14.65 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot Survey No. 50-P2, At Village Bileshwarpura Po. Chhatral, Ta. Kalol, Gandhinagar, Gujarat, 382729.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239GJ2011PLC067520

  • Registration Number

    067520

  • Incorporation Date

    18 October 2011

  • Authorized Capital

    ₹6.90 Cr

  • Paid-Up Capital

    ₹4.32 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.90 Cr
  • Paid Up Capital ₹ 4.32 Cr
  • Company Age 14 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 10.58 Cr
  • Satisfied Charges ₹ 14.65 Cr
  • Revenue Growth **** 9.44%
  • Profit Growth **** 51.01%
  • Ebitda **** -1.50%
  • Net Worth 129.90%
  • Total Assets -4.11%
Company report

Kesar Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kesar Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Kesar Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Parth Hemant Parikh Director 06 Sep 2019 Current
Kevin Atul Vasani Director 15 Apr 2025 Current
Prakash Ambalal Patel Director 18 Oct 2011 Current
Kalpesh Navnitlal Shah Director 01 May 2014 Current
Rumit Bharatbhai Gopani Director 15 Apr 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Sep 2019 Past
Pramod Abcsdd Additional Director 01 Nov 2019 Past
Pramod Abcsdd Additional Director 22 Feb 2021 Past
Pramod Abcsdd Director 06 Sep 2019 Past
Pramod Abcsdd Additional Director 29 Jan 2021 Past
Pramod Abcsdd Additional Director 29 Jan 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kesar Pharma.

Kesar Pharma Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 9.44% increase. The company also saw a substantial improvement in profitability, with a 51.01% increase in profit. The company's net worth Soared by an impressive increase of 129.9%.

Kesar Pharma revenue growth over time
Kesar Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.44%
*******
*******
*******
*******
Revenue from Operations
*******
 8.85%
*******
*******
*******
*******
Total Assets
*******
 -4.11%
*******
*******
*******
*******
Profit or Loss
*******
 51.01%
*******
*******
*******
*******
Net Worth
*******
 129.90%
*******
*******
*******
*******
EBITDA
*******
 -1.50%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kesar Pharma?

In 2024, Kesar Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹105,814,138.00

Satisfied Charges

₹146,500,000.00

Charges Breakdown by Lending Institutions
  • Hdb Financial Services Limited : 6.06 Cr
  • Sidbi : 2.53 Cr
  • Others : 1.99 Cr
Latest Charge Details
Date Lender Amount Status
31 Jan 2025 Hdb Financial Services Limited ₹6.06 Cr Open
05 Feb 2024 Sidbi ₹1.40 Cr Open
28 Mar 2023 Sidbi ₹6.28 M Open
06 Feb 2021 Others ₹5.50 M Open
07 Sep 2020 Others ₹1.44 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Kesar Pharma?

Kesar Pharma has a workforce of 47 employees as of Feb 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kesar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kesar Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kesar Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Kesar Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    The activity Kevin Atul Vasani was appointed as a Director was appointed as a Director on 15 Apr 2025 & has been associated with this company since 9 months 29 days . was completed.

  • Director Appointment

    The activity Rumit Bharatbhai Gopani was appointed as a Director was appointed as a Director on 15 Apr 2025 & has been associated with this company since 9 months 29 days . was completed.

  • Balance Sheet

    Kesar Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 20 Dec 2019 via Charge ID 100310109 with Others was fully satisfied on 19 Feb 2025. was documented.

  • Charges

    The activity A charge with Hdb Financial Services Limited amounted to Rs. 6.06 Cr with Charge ID 101083682 was registered on 31 Jan 2025. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kesar Pharma Limited?

The CIN of Kesar Pharma Limited is U24239GJ2011PLC067520.

Where is Kesar Pharma Limited headquartered?

Kesar Pharma Limited is headquartered at Plot Survey No. 50-P2, At Village Bileshwarpura Po. Chhatral, Ta. Kalol, Gandhinagar, Gujarat, 382729.

When was Kesar Pharma Limited incorporated?

Kesar Pharma Limited was incorporated on 18 October 2011.

Who are the current directors of Kesar Pharma Limited?

The current directors of Kesar Pharma Limited are

What is the primary industry of Kesar Pharma Limited?

The primary industry of Kesar Pharma Limited is Manufacturing.

Is Kesar Pharma Limited a listed company?

Kesar Pharma Limited is unlisted.

What is the capital structure of Kesar Pharma Limited?

The authorized capital of Kesar Pharma Limited is ₹6.90 Cr, and the paid-up capital is ₹4.32 Cr.

What is the compliance status of Kesar Pharma Limited?

The compliance status of Kesar Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available